Clinical Trials
24 trialsNCT05851378 2026-05-27
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT07597759 2026-05-19
Phase IIT Trial of SNA009
SmartNuclide Biopharma
Phase EARLY_PHASE1 Completed
NCT04614909 2026-05-14
Study of Pamiparib in Newly Diagnosed and rGBM
St. Joseph's Hospital and Medical Center, Phoenix
Phase EARLY_PHASE1 Completed
NCT04895592 2026-05-14
Radiosurgery Before Surgery for the Treatment of Brain Metastases
Emory University
Phase EARLY_PHASE1 Completed
NCT07587996 2026-05-14
Exploratory Clinical Study of ¹⁷⁷Lu-CTR-FAPI in Patients With Metastatic Solid Tumors
Lanzhou University Second Hospital
Phase EARLY_PHASE1 Completed
NCT03387553 2026-05-07
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT03962647 2026-04-30
A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Completed
NCT04305925 2026-04-24
Focal Laser Ablation of Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01868087 2026-04-15
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT04028245 2026-04-15
SPARC-1
Columbia University
Phase EARLY_PHASE1 Completed
NCT03832985 2026-04-09
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
Phase EARLY_PHASE1 Completed
NCT05607017 2026-04-06
Losartan in Prevention of Radiation-Induced Heart Failure
Massachusetts General Hospital
Phase EARLY_PHASE1 Completed
NCT05704933 2026-04-06
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT04721886 2026-04-02
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT05873439 2026-04-01
Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT04278989 2026-03-25
Inhibition of Oral Tumorigenesis by Antitumor B
Medical College of Wisconsin
Phase EARLY_PHASE1 Completed
NCT04480645 2026-03-24
CivaDerm(TM) Surface Therapy Pilot Study
CivaTech Oncology
Phase EARLY_PHASE1 Completed
NCT04188665 2026-03-20
Using MASL to Combat Oral Cancer
Rowan University
Phase EARLY_PHASE1 Completed
NCT03276832 2026-03-19
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT05577416 2026-03-18
AB-218-IIT-201
Melbourne Health
Phase EARLY_PHASE1 Completed
NCT04298606 2026-03-17
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT06378398 2026-03-13
A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT04391595 2026-03-06
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
St. Joseph's Hospital and Medical Center, Phoenix
Phase EARLY_PHASE1 Completed